For the Quarter Ending September 2025
North America
• In United States, Gentamicin Sulphate Price Index rose in Q3 2025, driven by increasing production costs.
• Production costs increased in Q3 2025, influenced by rising industrial electricity prices in September 2025.
• Demand was supported by strengthened US consumer spending on healthcare in September 2025.
• The Price Index reflected upward pressure from a 3.0% year-over-year CPI increase in September 2025.
• A 2.6% year-over-year PPI increase in August 2025 signaled higher input costs for manufacturing.
• Demand outlook bolstered by a 5.42% year-over-year increase in retail sales in September 2025.
• Manufacturing backlogs and inventories continued to shrink in Q3 2025, impacting supply chain efficiency.
• Low unemployment at 4.3% in September 2025 supported healthcare spending, influencing demand.
• Upward pressure on natural gas prices in Q3 2025 contributed to higher production expenses.
Why did the price of Gentamicin Sulphate change in September 2025 in North America?
• Industrial electricity prices increased in September 2025, raising Gentamicin Sulphate production costs.
• US consumer spending on healthcare strengthened in September 2025, boosting Gentamicin Sulphate demand.
• A 3.0% year-over-year CPI increase in September 2025 elevated overall operational expenses.
APAC
• In China, the Gentamicin Sulphate Price Index fell in Q3 2025, influenced by a -2.3% PPI year-on-year in September.
• Gentamicin Sulphate production costs were mixed in Q3 2025, with softening sugar feedstock and slightly rising industrial electricity.
• Demand for Gentamicin Sulphate was supported by a 6.5% year-on-year increase in industrial production in September 2025.
• The Manufacturing Index contracted in September 2025, impacting overall industrial activity and API demand.
• Retail sales grew 3.0% year-on-year in September 2025, supporting demand for human and veterinary medicine products.
• Persistent overcapacity in China's chemical industry exerted downward pressure on Gentamicin Sulphate pricing in Q3 2025.
• Growing demand for pharmaceutical products among the geriatric population drove Gentamicin Sulphate consumption in Q3 2025.
• China's consumer confidence index of 89.6 in September 2025 reflected pessimistic sentiment, impacting discretionary healthcare spending.
Why did the price of Gentamicin Sulphate change in September 2025 in APAC?
• Falling factory-gate prices, with PPI at -2.3% year-on-year in September 2025, reduced pricing power.
• Persistent overcapacity in China's chemical industry created downward pressure on prices in Q3 2025.
• A contracting Manufacturing Index in September 2025 signaled reduced industrial activity, impacting API demand.
Europe
• In Germany, the Gentamicin Sulphate Price Index faced downward pressure in Q3 2025, as industrial production contracted (-1.0% in September 2025).
• Gentamicin Sulphate production costs remained elevated in Q3 2025, driven by high raw material and electricity prices.
• The Gentamicin Sulphate demand outlook was challenged by a contracting Manufacturing Index in September 2025.
• Germany's pharmaceutical market expanded moderately in Q3 2025, supporting Gentamicin Sulphate demand.
• Rising CPI (2.4% in September 2025) increased operational costs, while PPI (-1.7%) eased raw material pressures.
• Low unemployment (3.9% in September 2025) indirectly supported healthcare spending, despite low consumer confidence (-23.6).
• Modest retail sales growth (0.8% in September 2025) offered slight support to the broader economic environment.
• The Gentamicin Sulphate Price Forecast suggests continued pressure from high energy costs and weak industrial output.
Why did the price of Gentamicin Sulphate change in September 2025 in Europe?
• Contracting industrial production (-1.0% in September 2025) reduced overall demand for chemical inputs.
• Elevated electricity and natural gas prices in Q3 2025 sustained high Gentamicin Sulphate production costs.
• Mixed inflation signals, with rising CPI (2.4%) and falling PPI (-1.7%) in September 2025, impacted costs.
For the Quarter Ending December 2022
North America
The prices of Gentamicin Sulphate in the North American region plummeted with the end of fourth quarter 2022. As with the start of first half of q4 the prices remained on the upper side owing to consistent end-user demand. Inflation thus decreased substantially compared to September, even though it remained well above the upper boundary which in turn affected the market sentiments of Gentamicin Sulphate.
Following mid-q4 supply chain disruption started to subside along with shipping charges, which somewhat supported the positive price trend for Gentamicin Sulphate in the United States. With this the prices for Gentamicin Sulphate were recorded at USD 142605/MT CFR Los Angeles in November. Towards the end of year 2022 the prices declined significantly with stockpiled inventories among the market participants.
Asia Pacific
APAC region, particularly China, witnesses decreasing pricing trend for Gentamicin Sulphate throughout fourth quarter of 2022. Following previous month’s trend, the prices of Gentamicin Sulphate during October, inclined consistently as the inquiries remained on the higher side. Chinese manufacturing activity, one of the important factors for the country’s economy, has declined steadily in the fourth quarter as rising COVID-19 cases caused more disruptions in both the supply within the domestic market and the trading momentum across the international market. With this, the prices of Gentamicin Sulphate recorded during the mid-q4 was settled at USD 107950/MT FOB Shanghai. Overall, the prices of Gentamicin Sulphate, declined considerably with weaker demand and in China.
Europe
Prices for Gentamicin Sulphate vary throughout Europe in the fourth quarter of 2022. With the start of October, inquiries inclined again after witnessing a weak trend in the previous month. During, November, prices increased little and reached USD 154995/MT CFR Hamburg in Germany. Supply chain disruption decreased rapidly along with the shipping cost which supported the positive price trend of Gentamicin Sulphate in Germany. However, In December, inflation in Europe decreased for the second consecutive month as rising energy prices started to level out at the end of the year 2022. demand fell from the prior month due to a decrease in overseas orders, particularly from exporting countries like China. Thanksgiving holidays, however, kept the market participants' inventories higher and queries weaker.
For The Quarter Ending September 2022
North America
In the North American region, the Gentamicin sulfate API price showcased an incremented state throughout the third quarter of 2022, backed by healthy downstream requirements and supplier demand from the exporting countries, primarily from China. Furthermore, the zero-covid policy of China severely affected the supply of this API in the country, which kept the prices of Gentamicin Sulfate on the higher side. Additionally, the closure of some Chinese manufacturing activities due to the heat wave and a power constraint affected the trading activities of the united states, which resulted in delayed shipments at the ports of the US, in turn augmenting the price values of Gentamicin Sulfate during the third quarter. Overall, the price for Gentamicin sulfate at the end of September was assessed at USD 138550/MT CFR Los Angeles.
Asia Pacific
In the third quarter of 2022, the prices of Gentamicin Sulfate in the APAC region witnessed an inclined state backed by heightened customer inquiries. During the first half of Q3, the prices went high, which was supported by healthy demand with lesser inventories. Further, the zero-covid policies in China and halted manufacturing activities affected the region's supply momentum, which was the primary factor for higher values of Gentamicin Sulfate. Followed by the mid of Q3, the prices declined significantly in the Chinese market. Moreover, towards the termination of Q3, the prices rose considerably owing to the healthy demand side balanced by the domestic market's supply side. Overall, the price for Gentamicin sulfate at the end of September was assessed at USD 107060/MT FOB Shanghai.
Europe
During the third quarter of 2022, the European region's price for Gentamicin Sulfate followed the Asian market price trend, as it mainly depended on the import market. Its downstream demand from the domestic market kept moving upward as offtakes from the pharmaceutical sector increased during the first two halves of Q3. Also, the worsened climatic conditions and halted manufacturing activities in the exporting countries such as China affected the supplies in the importing countries, which supported the market sentiments of Gentamicin sulfate in France. Furthermore, port congestion delayed shipments, and rerouting activities further led to the higher price trend in the overall quarter. Moreover, towards the termination of Q3, the prices declined significantly of Gentamicin sulfate and got settled at USD 147515/MT CFR Hamburg.
For the Quarter Ending June 2022
North America
In the North American region, the Gentamicin sulfate API price witnessed an incremented state during the Second Quarter of 2022, backed by heightened offtake from various downstream sectors, mainly pharmaceutical sectors. Further, China, the leading exporter of Gentamicin sulfate API to this market, underwent a price hike of API during the Second Quarter owing to transport disruptions due to cargo shortages and rerouting activity. In addition, supply disruptions and labor shortages due to heightened downstream demand were another added factor resulting in higher Gentamycin sulfate prices. Towards the ending of second quarter the prices for Gentamicin sulphate were assembled at USD 127405/MT CFR Los Angeles with an average increment of 2.21 percent.
Asia Pacific
During the Second Quarter of 2022, the APAC region showcased an increasing market sentiment for Gentamicin sulfate. Offtake from various downstream pharmaceutical sectors was one of the important factors driving Gentamicin sulfate API prices. The prices rose significantly with an average inclination of 2.00% in China and were recorded at USD 104905/MT FOB Shanghai. China being the major exporter of API, surging covid cases resulted in a temporary lockdown in Shanghai and Beijing, affecting the trading activities and reduction in production capacity, which in turn affected the price value of Gentamicin sulfate in the region. Additionally, higher freight charges, owing to a shortage of containers, further impacted the cost of Gentamicin sulfate.
Europe
The European market witnessed an upward pricing trajectory during the second Quarter of 2022, supported by a higher production rate. In addition, the prices increased with increased downstream demand from various end-user pharmaceutical enterprises. Furthermore, surging demand resulted in lessened inventories with the traders, causing an incremented in the price value of Gentamicin sulfate in the market. China, a major exporter of API, saw a price surge owing to the disrupted trading activity mainly because of a shortage of cargoes, leading to heightened freight charges. Also, rerouting activities admit of Russian-Ukraine war caused the price for Gentamicin sulfate to spike high. Towards the ending of second quarter the prices for Gentamicin sulphate were assembled at USD 144905/MT CFR Los Angeles.
